Overview

  • Product nameRecombinant Human PEX7 protein
  • Protein lengthFull length protein

Description

  • NatureRecombinant
  • SourceEscherichia coli
  • Amino Acid Sequence
    • SpeciesHuman

Specifications

Our Abpromise guarantee covers the use of ab75666 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Western blot

    ELISA

    SDS-PAGE

  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

    Preservative: None
    Constituents: 20% Glycerol, 50mM Tris acetate, 1mM EDTA, pH 7.5

General Info

  • Alternative names
    • PBD9B
    • PCDP1
    • Peroxin 7
    • Peroxin-7
    • Peroxisomal PTS2 receptor
    • Peroxisomal targeting signal 2 receptor
    • Peroxisome biogenesis factor 7
    • Peroxisome targeting signal 2 receptor
    • PEX7
    • PEX7 protein
    • PEX7_HUMAN
    • PTS2 receptor
    • PTS2R
    • RCDP1
    • RD
    see all
  • FunctionBinds to the N-terminal PTS2-type peroxisomal targeting signal and plays an essential role in peroxisomal protein import.
  • Tissue specificityUbiquitous. Highest expression in pancreas, skeletal muscle and heart.
  • Involvement in diseaseDefects in PEX7 are the cause of peroxisome biogenesis disorder complementation group 11 (PBD-CG11) [MIM:614879]. PBD refers to a group of peroxisomal disorders arising from a failure of protein import into the peroxisomal membrane or matrix. The PBD group is comprised of four disorders: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum. The PBD group is genetically heterogeneous with at least 13 distinct genetic groups as concluded from complementation studies.
    Defects in PEX7 are the cause of rhizomelic chondrodysplasia punctata type 1 (RCDP1) [MIM:215100]. RCDP1 is characterized by rhizomelic shortening of femur and humerus, vertebral disorders, cataract, cutaneous lesions and severe mental retardation.
    Defects in PEX7 are the cause of peroxisome biogenesis disorder 9B (PBD9B) [MIM:614879]. A peroxisome biogenesis disorder with unusually mild clinical and biochemical manifestations. Affected individuals manifest a variable phenotype similar to, and in some cases indistinguishable from, classic Refsum disease. Variable features include ocular abnormalities, sensorimotor neuropathy, ichthyosis, deafness, chondrodysplasia punctata without rhizomelia or growth failure.
  • Sequence similaritiesBelongs to the WD repeat peroxin-7 family.
    Contains 6 WD repeats.
  • Cellular localizationPeroxisome. Cytoplasm.
  • Information by UniProt

Recombinant Human PEX7 protein images

  • SDS-PAGE showing ab75666 at approximately 36kDa.

References for Recombinant Human PEX7 protein (ab75666)

ab75666 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab75666.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"